CTKB
Cytek Biosciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.70
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.90x
- Price / sales
- 2.96x
- Price / cash flow
- -101.18x
Enterprise value
- Enterprise value
- $375.4M
- EV / sales
- 1.82x
- EV / EBITDA
- -13.82x
- EV / EBIT
- -8.41x
- Market cap
- $610.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026